2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for PFIZER

Period 2nd Quarter 2018 Filed Jul 20, 2018 Signed by Jennifer B. Young

Official filing
Firm
TARPLIN, DOWNS & YOUNG, LLC
Client
PFIZER
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
CHARLOTTE SPEARS IVANCIC Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner
ELIZABETH T MURRAY Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
PAMELA SMITH Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Health Issues HCR

PL 114-255 - 21st Century Cures, implementation S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 469 - Affordable and Safe Prescription Drug Importation Act H.R. 749 - Lower Drug Costs Through Competition Act H.R. 2430 - FDA Reauthorization Act of 2017 S. 2852 - Pandemic and All Hazards Preparedness Act no specific bills - innovation, non-interference, biosimilars, prescription drug access and affordability

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: S. 2852 (115th), S. 771 (115th), S. 469 (115th), H.R. 2430 (115th), H.R. 749 (115th), S. 637 (115th)

Medicare/Medicaid MMM

Medicare priorities, coverage and payment policies, discount cards, MedPAC S. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 3921 - Healthy Kids Act S. 1827 - Kids Act of 2017 no specific bill, Sunshine implementation, biosimilars, Part B, Medicare Part D, Smoking cessation, donut hole, Part D cliff

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 260 (115th), H.R. 849 (115th), H.R. 3921 (115th), S. 1827 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.